152 related articles for article (PubMed ID: 8655359)
1. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo.
Mahlknecht U; Herter M; Hoffmann MK; Niethammer D; Dannecker GE
Hum Immunol; 1996 Jan; 45(1):42-5. PubMed ID: 8655359
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the early response to TSST-1 reveals Vbeta-unrestricted extravasation, compartmentalization of the response, and unresponsiveness but not anergy to TSST-1.
Waclavicek M; Stich N; Rappan I; Bergmeister H; Eibl MM
J Leukoc Biol; 2009 Jan; 85(1):44-54. PubMed ID: 18923105
[TBL] [Abstract][Full Text] [Related]
3. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
4. Functional uncoupling of T-cell receptor engagement and Lck activation in anergic human thymic CD4+ T cells.
Fujimaki W; Iwashima M; Yagi J; Zhang H; Yagi H; Seo K; Imai Y; Imanishi K; Uchiyama T
J Biol Chem; 2001 May; 276(20):17455-60. PubMed ID: 11279170
[TBL] [Abstract][Full Text] [Related]
5. Comparison of peptide and superantigen-induced anergy in a peptide-specific polyclonal human T cell line.
Chu NR; Quaratino S; Feldmann M; Londei M
Int Immunol; 1995 Jul; 7(7):1057-63. PubMed ID: 8527403
[TBL] [Abstract][Full Text] [Related]
6. Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytes.
Wood SC; Holsapple MP
Fundam Appl Toxicol; 1993 Apr; 20(3):280-7. PubMed ID: 8504901
[TBL] [Abstract][Full Text] [Related]
7. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
8. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
9. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
Soares LR; Rivas A; Ruegg C; Engleman EG
Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.
Krakauer T; Stiles BG
Clin Diagn Lab Immunol; 1999 Jul; 6(4):594-8. PubMed ID: 10391869
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
12. Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation.
Mingari MC; Cambiaggi A; Vitale C; Schiavetti F; Bellomo R; Poggi A
Int Immunol; 1996 Feb; 8(2):203-9. PubMed ID: 8671605
[TBL] [Abstract][Full Text] [Related]
13. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
[TBL] [Abstract][Full Text] [Related]
14. The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching.
Jabara HH; Geha RS
Int Immunol; 1996 Oct; 8(10):1503-10. PubMed ID: 8921429
[TBL] [Abstract][Full Text] [Related]
15. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
16. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
17. A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
Cullen CM; Bonventre PF; Heeg H; Bluethmann H; Mountz JD; Edwards CK
Pathobiology; 1995; 63(6):293-304. PubMed ID: 8738468
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
[TBL] [Abstract][Full Text] [Related]
19. Superantigen and endotoxin synergize in the induction of lethal shock.
Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to beta-streptococcal superantigens.
Horiuchi N; Aiba S; Ozawa H; Sugawara S; Rikiishi H; Kumagai K; Tagami H
Br J Dermatol; 1998 Feb; 138(2):229-35. PubMed ID: 9602866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
